Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A 32-Week Evaluation. Ozden S, Tepetam FM, Bozkurt Y, Terzioglu Sahin F, et al. Int Arch Allergy Immunol 2026 Jan 5:1-12. doi: 10.1159/000550316.

Read + Share

Amedeo Smart

Independent Medical Education

Ozden S, Tepetam FM, Bozkurt Y, Terzioglu Sahin F, et al. Real-World Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A 32-Week Evaluation. Int Arch Allergy Immunol 2026 Jan 5:1-12. doi: 10.1159/000550316.
PMID: 41490167